Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Erin Amor


Trials Administrator

I am a Research Administrator working in the Health Behaviours team, which looks at interventions to prevent or treat ill health relating to diet, obesity and smoking.

I am currently primarily working on two studies. The New DAWN study is for people who are overweight and have been recently diagnosed with type 2 diabetes. We know that losing weight can put diabetes into remission and NewDAWN is testing a new treatment pathway to see whether it could be used to improve diabetes treatment and outcomes.

The DIAMOND programme is looking to see how effective a low-energy, low-carbohydrate behavioural programme is for people with Type 2 Diabetes (T2DM) and whether it improves the chances of remission.

I also provide support on the LightCOM study, a collaboration between researchers in Denmark and Oxford that is testing a new weight-loss programme; and the ARIADNE study, investigating the impact of total diet replacement for type 2 diabetes remission on disorder eating.